![Dominic Piscitelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Piscitelli
Finanzdirektor/CFO bei
ORIC PHARMACEUTICALS, INC.
Vermögen: 575 851 $ am 31.05.2026
Profil
Dominic Piscitelli is currently an Independent Director at Celyad Oncology SA since 2020, an Independent Director at Alterome Therapeutics, Inc. since 2024, and Chief Financial Officer at Oric Pharmaceuticals, Inc. since 2019.
Former roles include Chief Financial Officer at AnaptysBio, Inc. from 2017 to 2019, VP-Finance, Strategy & Investor Relations at Medivation LLC (California) from 2012 to 2017, Director-Collaborations & Operations Finance at Astellas Pharmaceuticals SA from 2011 to 2012, and Vice President-Treasury & Management Finance at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Education includes undergraduate and MBAistration degrees from Hofstra University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 68’148 ( 0.07% ) | 575 851 $ | 31.05.2026 |
Aktive Positionen von Dominic Piscitelli
| Unternehmen | Position | Beginn |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.09.2019 |
| CELYAD ONCOLOGY SA | Direktor/Vorstandsmitglied | 06.05.2020 |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Direktor/Vorstandsmitglied | 01.04.2024 |
Ehemalige bekannte Positionen von Dominic Piscitelli
| Unternehmen | Position | Ende |
|---|---|---|
| ANAPTYSBIO, INC. | Finanzdirektor/CFO | 16.08.2019 |
| MEDIVATION INC | Finanzdirektor/CFO | 01.01.2017 |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 01.09.2012 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Dominic Piscitelli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Astellas Pharmaceuticals SA | |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
